nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP2A6—Methimazole—Graves' disease	0.246	0.274	CbGbCtD
Phenobarbital—CYP2E1—Methimazole—Graves' disease	0.162	0.181	CbGbCtD
Phenobarbital—CYP2B6—Methimazole—Graves' disease	0.16	0.178	CbGbCtD
Phenobarbital—CYP2C19—Methimazole—Graves' disease	0.102	0.113	CbGbCtD
Phenobarbital—CYP1A2—Methimazole—Graves' disease	0.0938	0.105	CbGbCtD
Phenobarbital—CYP2C9—Methimazole—Graves' disease	0.0845	0.0942	CbGbCtD
Phenobarbital—CYP3A4—Methimazole—Graves' disease	0.0491	0.0548	CbGbCtD
Phenobarbital—Liver injury—Propylthiouracil—Graves' disease	0.00659	0.101	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00427	0.0652	CcSEcCtD
Phenobarbital—Drowsiness—Methimazole—Graves' disease	0.00365	0.0558	CcSEcCtD
Phenobarbital—Hepatitis—Methimazole—Graves' disease	0.00328	0.0501	CcSEcCtD
Phenobarbital—Drowsiness—Propylthiouracil—Graves' disease	0.0031	0.0474	CcSEcCtD
Phenobarbital—Hepatitis—Propylthiouracil—Graves' disease	0.00279	0.0426	CcSEcCtD
Phenobarbital—Vertigo—Methimazole—Graves' disease	0.00256	0.0392	CcSEcCtD
Phenobarbital—Myalgia—Methimazole—Graves' disease	0.00243	0.0371	CcSEcCtD
Phenobarbital—Arthralgia—Methimazole—Graves' disease	0.00243	0.0371	CcSEcCtD
Phenobarbital—Vertigo—Propylthiouracil—Graves' disease	0.00218	0.0333	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00212	0.0324	CcSEcCtD
Phenobarbital—Somnolence—Methimazole—Graves' disease	0.00207	0.0316	CcSEcCtD
Phenobarbital—Arthralgia—Propylthiouracil—Graves' disease	0.00207	0.0316	CcSEcCtD
Phenobarbital—Myalgia—Propylthiouracil—Graves' disease	0.00207	0.0316	CcSEcCtD
Phenobarbital—Urticaria—Methimazole—Graves' disease	0.00185	0.0283	CcSEcCtD
Phenobarbital—Body temperature increased—Methimazole—Graves' disease	0.00184	0.0281	CcSEcCtD
Phenobarbital—CYP4B1—pituitary gland—Graves' disease	0.00181	0.0723	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0018	0.0276	CcSEcCtD
Phenobarbital—CYP4B1—adipose tissue—Graves' disease	0.0018	0.072	CbGeAlD
Phenobarbital—Somnolence—Propylthiouracil—Graves' disease	0.00176	0.0269	CcSEcCtD
Phenobarbital—Heptabarbital—GABRA3—Graves' disease	0.00175	0.141	CrCbGaD
Phenobarbital—Urticaria—Propylthiouracil—Graves' disease	0.00157	0.024	CcSEcCtD
Phenobarbital—Body temperature increased—Propylthiouracil—Graves' disease	0.00156	0.0239	CcSEcCtD
Phenobarbital—CYP4B1—thyroid gland—Graves' disease	0.00156	0.0623	CbGeAlD
Phenobarbital—Butethal—GABRA3—Graves' disease	0.00151	0.122	CrCbGaD
Phenobarbital—Vomiting—Methimazole—Graves' disease	0.00148	0.0226	CcSEcCtD
Phenobarbital—Rash—Methimazole—Graves' disease	0.00147	0.0224	CcSEcCtD
Phenobarbital—GRIK2—eye—Graves' disease	0.00147	0.0587	CbGeAlD
Phenobarbital—Dermatitis—Methimazole—Graves' disease	0.00147	0.0224	CcSEcCtD
Phenobarbital—Headache—Methimazole—Graves' disease	0.00146	0.0223	CcSEcCtD
Phenobarbital—Aprobarbital—GABRA3—Graves' disease	0.00146	0.118	CrCbGaD
Phenobarbital—SLCO2A1—eye—Graves' disease	0.00146	0.0583	CbGeAlD
Phenobarbital—Amobarbital—GABRA3—Graves' disease	0.00141	0.114	CrCbGaD
Phenobarbital—Primidone—GABRA3—Graves' disease	0.0014	0.113	CrCbGaD
Phenobarbital—Nausea—Methimazole—Graves' disease	0.00138	0.0211	CcSEcCtD
Phenobarbital—Methylphenobarbital—GABRA3—Graves' disease	0.00132	0.106	CrCbGaD
Phenobarbital—Vomiting—Propylthiouracil—Graves' disease	0.00126	0.0192	CcSEcCtD
Phenobarbital—Secobarbital—GABRA3—Graves' disease	0.00126	0.101	CrCbGaD
Phenobarbital—Rash—Propylthiouracil—Graves' disease	0.00125	0.0191	CcSEcCtD
Phenobarbital—Dermatitis—Propylthiouracil—Graves' disease	0.00125	0.0191	CcSEcCtD
Phenobarbital—Headache—Propylthiouracil—Graves' disease	0.00124	0.019	CcSEcCtD
Phenobarbital—CHRNA7—eye—Graves' disease	0.0012	0.0478	CbGeAlD
Phenobarbital—Pentobarbital—GABRA3—Graves' disease	0.00118	0.0956	CrCbGaD
Phenobarbital—Nausea—Propylthiouracil—Graves' disease	0.00118	0.018	CcSEcCtD
Phenobarbital—Talbutal—GABRA3—Graves' disease	0.00109	0.0879	CrCbGaD
Phenobarbital—SLCO2A1—pituitary gland—Graves' disease	0.00108	0.0432	CbGeAlD
Phenobarbital—SLCO2A1—adipose tissue—Graves' disease	0.00108	0.0431	CbGeAlD
Phenobarbital—CHRFAM7A—thyroid gland—Graves' disease	0.000947	0.0379	CbGeAlD
Phenobarbital—SLCO2A1—thyroid gland—Graves' disease	0.000932	0.0373	CbGeAlD
Phenobarbital—CYP2A6—adipose tissue—Graves' disease	0.000883	0.0353	CbGeAlD
Phenobarbital—CYP1B1—eye—Graves' disease	0.000876	0.035	CbGeAlD
Phenobarbital—CYP1B1—connective tissue—Graves' disease	0.000844	0.0337	CbGeAlD
Phenobarbital—ABCC3—adipose tissue—Graves' disease	0.000827	0.0331	CbGeAlD
Phenobarbital—CHRNA7—thyroid gland—Graves' disease	0.000765	0.0306	CbGeAlD
Phenobarbital—ABCC3—thyroid gland—Graves' disease	0.000716	0.0286	CbGeAlD
Phenobarbital—CYP1B1—pituitary gland—Graves' disease	0.00065	0.026	CbGeAlD
Phenobarbital—CYP1B1—adipose tissue—Graves' disease	0.000647	0.0259	CbGeAlD
Phenobarbital—ABCC1—pituitary gland—Graves' disease	0.000585	0.0234	CbGeAlD
Phenobarbital—ABCC1—adipose tissue—Graves' disease	0.000582	0.0233	CbGeAlD
Phenobarbital—CYP1B1—thyroid gland—Graves' disease	0.00056	0.0224	CbGeAlD
Phenobarbital—ABCC1—thyroid gland—Graves' disease	0.000504	0.0202	CbGeAlD
Phenobarbital—CYP2C8—pituitary gland—Graves' disease	0.000498	0.0199	CbGeAlD
Phenobarbital—CYP1A1—adipose tissue—Graves' disease	0.000458	0.0183	CbGeAlD
Phenobarbital—CYP3A5—adipose tissue—Graves' disease	0.000447	0.0179	CbGeAlD
Phenobarbital—CYP1A2—thyroid gland—Graves' disease	0.000401	0.0161	CbGeAlD
Phenobarbital—CYP1A1—thyroid gland—Graves' disease	0.000396	0.0158	CbGeAlD
Phenobarbital—CYP2E1—thyroid gland—Graves' disease	0.000361	0.0144	CbGeAlD
Phenobarbital—ABCB1—pituitary gland—Graves' disease	0.000239	0.00954	CbGeAlD
Phenobarbital—ABCB1—adipose tissue—Graves' disease	0.000238	0.00951	CbGeAlD
Phenobarbital—ABCB1—thyroid gland—Graves' disease	0.000206	0.00823	CbGeAlD
